Allergenicity and Bioavailability of Nickel Nanoparticles Compared to Nickel Microparticles in Mice.
nickel allergy
nickel allergy model mice
nickel nanoparticles
Journal
Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929
Informations de publication
Date de publication:
23 Feb 2023
23 Feb 2023
Historique:
received:
16
12
2022
revised:
20
02
2023
accepted:
21
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
Metal allergy is a common disease that afflicts many people. Nevertheless, the mechanism underlying metal allergy development has not been completely elucidated. Metal nanoparticles might be involved in the development of a metal allergy, but the associated details are unknown. In this study, we evaluated the pharmacokinetics and allergenicity of nickel nanoparticles (Ni-NPs) compared with those of nickel microparticles (Ni-MPs) and nickel ions. After characterizing each particle, the particles were suspended in phosphate-buffered saline and sonicated to prepare a dispersion. We assumed the presence of nickel ions for each particle dispersion and positive control and orally administered nickel chloride to BALB/c mice repeatedly for 28 days. Results showed that compared with those in the Ni-MP administration group (MP group), the Ni-NP administration group (NP group) showed intestinal epithelial tissue damage, elevated serum interleukin (IL)-17 and IL-1β levels, and higher nickel accumulation in the liver and kidney. Additionally, transmission electron microscopy confirmed the accumulation of Ni-NPs in the livers of both the NP and nickel ion administration groups. Furthermore, we intraperitoneally administered a mixed solution of each particle dispersion and lipopolysaccharide to mice and then intradermally administered nickel chloride solution to the auricle after 7 days. Swelling of the auricle was observed in both the NP and MP groups, and an allergic reaction to nickel was induced. Particularly in the NP group, significant lymphocytic infiltration into the auricular tissue was observed, and serum IL-6 and IL-17 levels were increased. The results of this study showed that in mice, Ni-NP accumulation in each tissue was increased after oral administration and toxicity was enhanced, as compared to those with Ni-MPs. Orally administered nickel ions transformed into nanoparticles with a crystalline structure and accumulated in tissues. Furthermore, Ni-NPs and Ni-MPs induced sensitization and nickel allergy reactions in the same manner as that with nickel ions, but Ni-NPs induced stronger sensitization. Additionally, the involvement of Th17 cells was suspected in Ni-NP-induced toxicity and allergic reactions. In conclusion, oral exposure to Ni-NPs results in more serious biotoxicity and accumulation in tissues than Ni-MPs, suggesting that the probability of developing an allergy might increase.
Identifiants
pubmed: 36902949
pii: ma16051834
doi: 10.3390/ma16051834
pmc: PMC10004360
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Appl Toxicol. 2019 Jul;39(7):1012-1029
pubmed: 30843265
Dermatol Ther. 2004;17(4):321-7
pubmed: 15327477
J Am Dent Assoc. 1998 Oct;129(10):1435-41
pubmed: 9787540
Sci Total Environ. 2009 Feb 1;407(4):1461-8
pubmed: 19038417
Clin Exp Allergy. 2017 Aug;47(8):1069-1078
pubmed: 28319310
Contact Dermatitis. 1997 Nov;37(5):200-9
pubmed: 9412746
Nanotoxicology. 2016;10(2):151-61
pubmed: 25916264
Dermatol Res Pract. 2012;2012:749561
pubmed: 22693488
J Environ Monit. 2011 May;13(5):1156-63
pubmed: 21505694
Environ Geochem Health. 2020 Jul;42(7):2277-2286
pubmed: 31894452
Chem Res Toxicol. 2010 Feb 15;23(2):309-18
pubmed: 19831422
Int J Prosthodont. 1995 Jul-Aug;8(4):351-9
pubmed: 7575978
Nanoscale Res Lett. 2019 May 28;14(1):180
pubmed: 31139947
Part Fibre Toxicol. 2005 Oct 06;2:8
pubmed: 16209704
J Nanobiotechnology. 2019 Jan 7;17(1):2
pubmed: 30616599
Br J Dermatol. 2011 Nov;165(5):1022-9
pubmed: 21692768
J Immunol. 2004 Feb 1;172(3):1926-34
pubmed: 14734778
Curr Opin Immunol. 2008 Feb;20(1):89-95
pubmed: 18249105
Med Oral. 2003 Nov-Dec;8(5):334-47
pubmed: 14595258
J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):177-82
pubmed: 10642670
Dent Mater J. 2014;33(2):187-95
pubmed: 24583645
Crit Rev Toxicol. 2011 Feb;41(2):142-74
pubmed: 21158697
Clin Exp Allergy. 2007 May;37(5):743-51
pubmed: 17456222
Dent Mater. 2017 Nov;33(11):1298-1314
pubmed: 28951037
Immunol Rev. 2011 Jul;242(1):51-68
pubmed: 21682738
Contact Dermatitis. 2007 Nov;57(5):287-99
pubmed: 17937743
Biochem J. 2004 Jan 1;377(Pt 1):159-69
pubmed: 14505488
Immunity. 2011 Feb 25;34(2):149-62
pubmed: 21349428
Part Fibre Toxicol. 2021 Mar 19;18(1):13
pubmed: 33740985
Am J Orthod Dentofacial Orthop. 1993 Mar;103(3):280-5
pubmed: 8456786
Int Immunopharmacol. 2011 Oct;11(10):1534-40
pubmed: 21621645
Swiss Dent J. 2019 Jul 22;129(7-8):571-579
pubmed: 31305034
Nat Nanotechnol. 2016 Sep;11(9):808-16
pubmed: 27240418
PLoS One. 2016 Jul 19;11(7):e0159684
pubmed: 27434640
Small. 2012 Feb 6;8(3):404-12
pubmed: 22144073
ACS Nano. 2012 Aug 28;6(8):7427-42
pubmed: 22857815
Inhal Toxicol. 2008 Apr;20(6):575-83
pubmed: 18444010
Environ Toxicol Pharmacol. 2012 Nov;34(3):644-50
pubmed: 23000472
Allergy. 2000 Feb;55(2):108-15
pubmed: 10726725
Clin Rev Allergy Immunol. 2019 Feb;56(1):9-18
pubmed: 29766368
Toxicol In Vitro. 2010 Apr;24(3):872-8
pubmed: 19969064